Hub : Traits :

Chronotype (morning person)

485 significantly associated models · 171 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	7135268	8695522	3	2	1.9e-25	4.6e-24	2.3e-03	91	TNFRSF9 VAMP3
2	1	15569712	16098866	1	1	1.3e-07	1.3e-07	5.8e-02	87	CASP9
3	1	19293249	22200998	5	2	5.5e-12	8.3e-12	8.8e-01	100	HP1BP3 HTR6
4	1	37270283	38679381	1	1	1.9e-07	1.0e-07	2.1e-01	95	MEAF6
5	1	92608852	94120642	1	1	2.2e-08	9.0e-08	2.0e-01	94	FAM69A
6	1	109126153	110834259	4	2	3.0e-10	5.7e-12	NaN	NaN	AMIGO1 GNAI3
7	1	114417843	115823387	2	1	1.5e-09	1.9e-08	1.9e-02	82	TRIM33
8	1	149672809	151659071	14	10	3.7e-16	6.3e-15	1.0e+00	100	ANXA9 C1orf54 CTSS GOLPH3L MRPS21 RPRD2 SETDB1 TARS2
9	1	179566296	180095451	1	1	7.7e-08	1.5e-04	1.3e-03	28	TOR1AIP2
10	1	181669986	183058898	1	1	3.1e-08	1.2e-39	3.5e-33	17	GLUL
11	2	43844833	45285952	1	1	5.7e-09	1.7e-11	3.1e-04	71	PREPL
12	2	48072855	49519654	2	2	1.1e-09	2.9e-09	1.0e+00	100	LHCGR STON1
13	2	60707588	62107632	1	1	1.6e-07	2.5e-10	2.8e-04	67	AHSA2
14	2	197745121	200117777	3	1	2.6e-09	1.1e-11	3.1e-05	62	PLCL1
15	2	238435241	239996179	3	2	7.3e-24	3.9e-25	1.0e+00	100	KLHL30 TRAF3IP1
16	3	22551223	24327558	1	1	1.3e-07	1.5e-08	3.3e-03	73	UBE2E2
17	3	48012797	51320800	18	12	1.1e-14	9.2e-12	NaN	NaN	BSN CYB561D2 HYAL1 RASSF1 SEMA3B-AS1 SEMA3F TCTA U73166.2
18	3	132509832	133350222	1	1	1.0e-09	8.0e-09	1.7e-02	83	TMEM108
19	4	305291	2058475	5	1	1.9e-13	2.9e-08	6.1e-02	89	UVSSA
20	4	82578407	84048087	2	2	1.0e-08	5.0e-11	2.1e-03	78	HNRNPD HNRNPDL
21	5	86867897	88427942	1	1	2.5e-09	1.2e-09	4.5e-06	43	TMEM161B-AS1
22	5	151529317	152030714	1	1	6.1e-09	3.2e-12	1.8e-05	62	NMUR2
23	6	41058968	42450682	2	3	3.8e-09	4.2e-10	6.9e-02	92	FOXP4 PRICKLE4
24	6	152608067	154022718	2	2	7.5e-09	2.5e-19	4.8e-13	35	MTRF1L RP1-101K10.6
25	7	49817957	51215365	2	1	6.1e-08	5.4e-11	1.0e-04	65	FIGNL1
26	7	101330734	103489729	14	11	1.5e-13	2.8e-14	NaN	NaN	ARMC10 NAPEPLD PMPCB POLR2J3 PRKRIP1 RASA4 RP11-514P8.6 RP11-514P8.8 SLC26A5
27	7	115680998	116397572	1	1	2.9e-07	1.0e-08	5.2e-04	63	CAV2
28	8	101232701	102664291	1	1	2.7e-10	1.2e-09	6.8e-01	100	YWHAZ
29	9	36590588	37277603	1	1	8.7e-11	9.4e-10	1.8e-02	85	PAX5
30	9	85899677	87315117	2	1	2.1e-09	3.6e-09	3.2e-01	97	RMI1
31	9	114896872	115476640	1	1	4.2e-08	2.1e-08	1.8e-01	94	HSDL2
32	9	126421143	127872298	1	1	6.0e-08	1.0e-09	5.8e-09	9	PSMB7
33	9	131169528	132569553	4	1	7.9e-10	5.2e-10	3.9e-03	78	PPP2R4
34	9	138605924	141054761	4	2	6.2e-10	5.8e-08	6.1e-02	88	MRPL41 SDCCAG3
35	10	103807817	105275242	1	1	2.3e-07	3.2e-06	5.6e-01	98	C10orf26
36	10	122989048	124407934	1	1	1.9e-07	5.0e-08	5.6e-05	45	RP11-500G22.2
37	11	29713564	31288160	1	1	5.1e-09	2.5e-09	7.2e-03	80	MPPED2
38	11	46578400	48028343	4	1	7.3e-15	1.1e-07	4.6e-01	98	MADD
39	11	56716782	58178587	2	1	5.6e-08	7.7e-10	2.2e-06	41	AP000662.4
40	11	65151449	66919278	4	2	6.2e-08	2.5e-07	9.3e-02	89	CTD-3074O7.5 PACS1
41	12	32831091	34826574	2	3	1.3e-18	1.1e-25	4.3e-05	85	ALG10 SYT10
42	12	38353816	39998144	3	2	5.4e-24	4.4e-26	4.7e-02	96	ALG10B RP11-396F22.1
43	12	106675236	108179234	2	2	1.6e-07	1.8e-08	3.8e-03	74	CRY1 MTERFD3
44	12	111385296	113517494	3	1	4.6e-08	5.3e-09	3.5e-02	87	HECTD4
45	12	120242845	121660787	2	1	2.9e-08	3.4e-07	5.1e-02	85	COQ5
46	13	76867667	78295338	2	1	2.8e-16	3.5e-17	1.0e+00	100	CLN5
47	13	93183161	95758325	1	1	9.5e-09	1.2e-08	1.0e+00	100	GPC6
48	14	60517036	62134085	1	1	1.1e-07	9.4e-06	1.9e-02	72	MNAT1
49	14	73724767	75366447	2	1	9.9e-08	5.7e-07	1.0e+00	100	LIN52
50	14	88690885	89265337	1	1	5.2e-08	3.9e-07	6.9e-02	87	PTPN21
51	14	100766664	101281436	1	1	1.2e-07	3.7e-08	1.5e-02	80	BEGAIN
52	16	52828325	54235440	1	1	2.7e-07	1.5e-20	9.0e-15	30	AKTIP
53	16	55697964	57157206	1	1	1.1e-08	1.1e-15	3.1e-10	38	AMFR
54	16	71380320	72800567	1	1	4.2e-08	8.7e-10	5.3e-03	79	TXNL4B
55	17	7379650	8823768	3	1	3.6e-15	2.8e-15	1.0e+00	100	TMEM107
56	17	33204020	35123256	4	1	1.4e-10	7.2e-09	1.0e+00	100	AP2B1
57	17	45337417	46721406	1	1	1.1e-07	1.4e-06	4.2e-01	97	RP11-6N17.6
58	17	56362067	57989860	3	1	1.2e-08	5.5e-08	1.7e-01	94	TRIM37
59	17	60399470	62212520	2	1	5.0e-08	4.3e-09	1.1e-03	69	CYB561
60	18	52750469	54144903	1	1	8.9e-11	1.4e-08	2.5e-02	84	RP11-397A16.2
61	18	56118999	57521875	1	1	1.4e-12	3.6e-16	5.3e-05	75	SEC11C
62	19	17412366	18811966	1	1	4.7e-08	4.3e-08	7.9e-04	62	ARRDC2
63	19	36694438	37221835	1	1	1.0e-07	2.3e-05	3.7e-01	96	ZNF566
64	19	42331992	42820530	1	1	3.3e-09	2.2e-06	6.3e-01	99	ZNF574
65	19	45313715	46693262	1	1	7.9e-08	2.5e-06	1.1e-05	13	PPM1N
66	19	46754714	47235715	1	1	2.3e-07	5.5e-08	1.3e-02	79	PNMAL2
67	19	58244898	59095126	3	1	1.5e-07	2.1e-07	4.1e-01	98	ZNF584
68	22	40500313	41047764	2	1	5.8e-16	1.3e-16	1.0e+00	100	SGSM3
69	22	41498627	43226599	3	1	1.0e-08	1.0e-09	2.2e-07	28	SLC25A5P1

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Blood Red Count	3.85	21	14	31.1	-0.40	5.9e-02	CTD-3074O7.5 CYB561D2 FAM69A FIGNL1 HECTD4 HP1BP3 LIN52 MEAF6 PPM1N PPP2R4 PRICKLE4 RASSF1 RP11-6N17.6 SEMA3B-AS1 SGSM3 TCTA TOR1AIP2 TRIM33 UBE2E2 VAMP3 ZNF584
Ever unenthusiastic/disinterested for a whole week	2.78	6	0	0.0	-0.99	6.2e-06	BSN HYAL1 RASSF1 SEMA3F TCTA U73166.2
Comparative body size at age 10	2.63	10	3	6.7	0.67	1.6e-02	AKTIP CYB561D2 GNAI3 HNRNPD HYAL1 MADD RASSF1 SEMA3B-AS1 SETDB1 U73166.2
Frequency of depressed mood in last 2 weeks	2.53	5	0	0.0	-0.99	1.6e-05	AP000662.4 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Impedance of leg (right)	2.48	19	13	28.9	-0.60	3.1e-03	AKTIP C1orf54 CTD-3074O7.5 CTSS CYB561D2 GOLPH3L HNRNPD HYAL1 MADD MPPED2 MRPS21 PLCL1 RASSF1 RP11-6N17.6 RPRD2 SEMA3B-AS1 TARS2 U73166.2 YWHAZ
Worry (Nagel 2018)	2.41	7	5	11.1	-0.84	1.1e-03	CYB561D2 HP1BP3 HYAL1 RASSF1 RMI1 SEMA3B-AS1 U73166.2
Depression (Nagel 2018)	2.35	5	0	0.0	-0.99	1.3e-06	AP000662.4 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Impedance of leg (left)	2.33	17	11	24.4	-0.69	7.2e-04	AKTIP C1orf54 CTD-3074O7.5 CYB561D2 HNRNPD HYAL1 MADD MPPED2 MRPS21 PLCL1 RASSF1 RP11-6N17.6 RPRD2 SEMA3B-AS1 TARS2 U73166.2 YWHAZ
Friendships satisfaction	2.33	4	0	0.0	0.55	4.5e-01	MRPS21 RP11-397A16.2 RPRD2 TARS2
Impedance of whole body	2.32	19	12	26.7	-0.34	1.2e-01	AKTIP CTD-3074O7.5 CYB561D2 GOLPH3L HNRNPD HYAL1 MPPED2 PLCL1 PSMB7 RASSF1 RMI1 RP11-6N17.6 RPRD2 SEMA3B-AS1 SEMA3F TARS2 TCTA U73166.2 YWHAZ
Pulse rate, automated reading	2.29	13	6	13.3	0.37	1.6e-01	ALG10 ALG10B AP000662.4 BSN HNRNPD PRICKLE4 RASSF1 RP11-396F22.1 SEMA3B-AS1 SYT10 TCTA TMEM161B-AS1 UVSSA
Tense / 'highly strung'	2.26	5	1	2.2	-0.99	4.7e-05	CYB561D2 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Bipolar Disorder (2011)	2.25	2	0	0.0	0.00	1.0e+00	CTD-3074O7.5 PACS1
Ulcerative Colitis	2.25	4	1	2.2	1.00	4.0e-03	HYAL1 POLR2J3 SEMA3F TCTA
Seen doctor (GP) for nerves, anxiety, tension or depression	2.25	2	1	2.2	0.00	1.0e+00	CTD-3074O7.5 PAX5
Frequency of unenthusiasm / disinterest in last 2 weeks	2.22	4	0	0.0	-1.00	1.4e-05	AP000662.4 HYAL1 RASSF1 U73166.2
Age when periods started (menarche)	2.21	10	5	11.1	-0.38	2.5e-01	AKTIP BSN C1orf54 HYAL1 MADD PRICKLE4 RP11-500G22.2 SEMA3F TCTA ZNF584
Neuroticism score	2.19	9	5	11.1	-0.85	4.4e-04	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Impedance of arm (right)	2.18	17	11	24.4	-0.17	4.6e-01	AKTIP CYB561D2 GOLPH3L HNRNPD HYAL1 NAPEPLD PLCL1 PPP2R4 PSMB7 RASA4 RASSF1 RMI1 RP11-6N17.6 SEMA3B-AS1 SEMA3F U73166.2 YWHAZ
Taking other prescription medications	2.15	3	2	4.4	-0.99	1.1e-02	HYAL1 RASSF1 SEMA3F
Nervous feelings	2.12	7	2	4.4	-0.74	2.2e-02	CYB561D2 HYAL1 MNAT1 RASSF1 SEMA3B-AS1 U73166.2 UVSSA
Frequency of tiredness / lethargy in last 2 weeks	2.12	4	0	0.0	-1.00	7.3e-04	AP000662.4 BSN HECTD4 TCTA
Relative age of first facial hair	2.10	7	1	2.2	-0.47	2.4e-01	AHSA2 BSN CYB561D2 HYAL1 PRICKLE4 RASSF1 ZNF584
Worrier / anxious feelings	2.10	5	3	6.7	-0.98	7.1e-04	HP1BP3 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
BMI	2.09	22	10	22.2	0.17	4.5e-01	AKTIP ARRDC2 CASP9 CTD-3074O7.5 FAM69A FIGNL1 GNAI3 HYAL1 MADD MPPED2 MTRF1L PAX5 PLCL1 PPM1N PSMB7 SEMA3F SETDB1 SGSM3 SLC25A5P1 TCTA TMEM161B-AS1 YWHAZ
Impedance of arm (left)	2.09	17	10	22.2	-0.18	4.4e-01	AKTIP CYB561D2 HNRNPD HYAL1 NAPEPLD PLCL1 PPP2R4 PSMB7 RASA4 RASSF1 RMI1 RP11-396F22.1 SEMA3B-AS1 SEMA3F TCTA U73166.2 YWHAZ
Pulse rate	2.01	3	1	2.2	0.99	8.0e-03	ALG10 ALG10B BSN
Schizophrenia vs Biploar Disorder	1.96	2	0	0.0	0.00	1.0e+00	PAX5 SEMA3F
Ulcerative Colitis (UC)	1.96	7	2	4.4	0.98	8.2e-05	AHSA2 GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1 TCTA
Ever highly irritable/argumentative for 2 days	1.96	3	2	4.4	0.00	1.0e+00	HYAL1 RASSF1 SEMA3F
Overall health rating	1.96	6	4	8.9	-0.80	3.0e-02	AP000662.4 HYAL1 PLCL1 RASSF1 SEMA3F TCTA
Prospective memory result	1.95	2	0	0.0	0.00	1.0e+00	MADD SETDB1
Irritable Bowel Disease (IBD)	1.93	8	5	11.1	0.99	6.4e-06	AHSA2 CTSS GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1 TCTA
Qualifications: College or University degree	1.93	11	3	6.7	0.27	4.2e-01	AP000662.4 BSN HYAL1 PACS1 PTPN21 SEMA3F SETDB1 SLC25A5P1 TCTA TMEM161B-AS1 TXNL4B
Type 2 Diabetes (T2D) (2018)	1.92	7	1	2.2	-0.31	4.5e-01	AKTIP PAX5 PMPCB POLR2J3 PPM1N PRKRIP1 RP11-514P8.6
Mean time to correctly identify matches	1.92	3	2	4.4	0.00	1.0e+00	HECTD4 PREPL RMI1
Reaction Time	1.91	4	2	4.4	0.42	4.8e-01	ALG10 HECTD4 PREPL RMI1
Body mass index (BMI)	1.89	12	8	17.8	0.15	6.3e-01	AKTIP CTD-3074O7.5 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 YWHAZ
Neuroticism (2016)	1.88	2	0	0.0	0.00	1.0e+00	PAX5 U73166.2
Lung FVC	1.87	20	6	13.3	-0.25	2.5e-01	ANXA9 BEGAIN C1orf54 CTSS CYB561D2 GOLPH3L HYAL1 MNAT1 MRPS21 PNMAL2 PRICKLE4 RASSF1 RMI1 SDCCAG3 SEMA3B-AS1 SETDB1 SLC25A5P1 TCTA U73166.2 ZNF574
Neuroticism (Nagel 2018)	1.86	9	3	6.7	-0.81	2.5e-03	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Body Mass Index (BMI) (2010)	1.86	1	1	2.2	0.00	1.0e+00	AKTIP
Frequency of tenseness / restlessness in last 2 weeks	1.82	2	0	0.0	0.00	1.0e+00	HYAL1 SEMA3F
Osteoarthritis (self-reported)	1.81	2	0	0.0	0.00	1.0e+00	MRPS21 RPRD2
Number of self-reported non-cancer illnesses	1.81	3	0	0.0	0.00	1.0e+00	HP1BP3 HYAL1 SEMA3F
Leg fat mass (right)	1.79	11	5	11.1	0.03	9.3e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F YWHAZ
Ever depressed for a whole week	1.79	1	0	0.0	0.00	1.0e+00	BSN
Medication: Omeprazole	1.78	3	0	0.0	0.00	1.0e+00	MRPS21 RPRD2 TARS2
Neuroticism	1.77	9	2	4.4	-0.78	7.6e-03	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Average weekly beer plus cider intake	1.76	4	1	2.2	-0.52	3.6e-01	HYAL1 PRICKLE4 SEMA3F TCTA
Bipolar Disorder (2018)	1.75	4	0	0.0	0.35	6.5e-01	CTD-3074O7.5 HTR6 PACS1 RPRD2
Arm fat mass (right)	1.75	14	7	15.6	0.12	6.9e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 SLC25A5P1 TMEM161B-AS1 YWHAZ
Arm fat mass (left)	1.75	14	6	13.3	0.13	6.6e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 SLC25A5P1 TMEM161B-AS1 YWHAZ
Alcohol intake versus 10 years previously	1.73	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Miserableness	1.73	3	3	6.7	0.00	1.0e+00	HYAL1 SEMA3F TCTA
High cholesterol (Self-reported)	1.73	4	1	2.2	0.93	6.6e-02	AMIGO1 CYB561D2 HYAL1 RP11-6N17.6
Leg fat mass (left)	1.73	11	5	11.1	0.04	9.0e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F YWHAZ
Blood Eosinophil Count	1.72	19	12	26.7	-0.18	4.2e-01	AHSA2 CTSS CYB561D2 FOXP4 GOLPH3L HECTD4 HNRNPDL HP1BP3 HYAL1 MRPS21 PSMB7 RASSF1 RMI1 SDCCAG3 SEMA3F SETDB1 TARS2 TNFRSF9 ZNF574
Leg fat percentage (right)	1.71	9	4	8.9	-0.31	4.2e-01	AKTIP GNAI3 HECTD4 HNRNPD HYAL1 PAX5 POLR2J3 RPRD2 SEMA3F
Smoking Status	1.70	5	1	2.2	-0.78	1.2e-01	BSN SGSM3 SLC25A5P1 TCTA TMEM161B-AS1
Pack years of smoking	1.69	1	0	0.0	0.00	1.0e+00	CYB561
Birth weight	1.68	3	1	2.2	0.00	1.0e+00	C10orf26 MRPS21 TARS2
Whole body fat mass	1.68	11	6	13.3	-0.10	7.8e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F YWHAZ
Arm fat percentage (left)	1.68	11	5	11.1	0.13	7.0e-01	AKTIP CTD-3074O7.5 GNAI3 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F SGSM3 TMEM161B-AS1
Arm fat percentage (right)	1.67	11	5	11.1	0.11	7.5e-01	AKTIP CTD-3074O7.5 GNAI3 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F SGSM3 TMEM161B-AS1
Diabetes diagnosed by doctor	1.67	5	0	0.0	-0.09	8.9e-01	AKTIP PMPCB POLR2J3 PPM1N PRKRIP1
Waist circumference	1.66	12	4	8.9	-0.03	9.2e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 MTRF1L PAX5 SEMA3F SGSM3 TRIM33
Diabetes (self-reported)	1.66	2	0	0.0	0.00	1.0e+00	PMPCB PPM1N
Average weekly red wine intake	1.66	1	1	2.2	0.00	1.0e+00	AP000662.4
Hip circumference	1.65	12	6	13.3	0.11	7.3e-01	AKTIP AMFR FIGNL1 GNAI3 HECTD4 MADD MPPED2 PAX5 PMPCB SEMA3F SETDB1 YWHAZ
Body fat percentage	1.65	11	5	11.1	0.11	7.6e-01	AKTIP BEGAIN GNAI3 GOLPH3L HNRNPD HYAL1 MADD PAX5 POLR2J3 RPRD2 SEMA3F
Family relationship satisfaction	1.65	1	0	0.0	0.00	1.0e+00	AMIGO1
Intelligence (Savage-Jansen 2018)	1.63	10	6	13.3	0.11	7.6e-01	HYAL1 MADD PLCL1 PPP2R4 RASSF1 RMI1 SEMA3F SLC25A5P1 TCTA TRIM37
LDL Cholesterol	1.63	3	1	2.2	0.00	1.0e+00	AMIGO1 GNAI3 HECTD4
Trunk fat mass	1.63	13	5	11.1	0.00	1.0e+00	AKTIP FIGNL1 GNAI3 HECTD4 HNRNPD HYAL1 MADD MPPED2 PAX5 POLR2J3 RMI1 SEMA3F TMEM161B-AS1
Weight	1.63	15	7	15.6	0.02	9.5e-01	AKTIP FIGNL1 GNAI3 GPC6 HECTD4 HYAL1 MADD MNAT1 MPPED2 PAX5 PLCL1 POLR2J3 SEMA3F SLC25A5P1 YWHAZ
Medication: Omeprazole (e.g. Zanprol)	1.63	1	0	0.0	0.00	1.0e+00	PRICKLE4
Trunk fat percentage	1.62	13	3	6.7	0.23	4.6e-01	AKTIP BEGAIN GNAI3 GOLPH3L HNRNPD HYAL1 MADD MPPED2 PAX5 POLR2J3 RMI1 SEMA3F TMEM161B-AS1
Health satisfaction	1.62	1	0	0.0	0.00	1.0e+00	RASSF1
Worry too long after embarrassment	1.61	2	1	2.2	0.00	1.0e+00	AP000662.4 HP1BP3
Leg fat percentage (left)	1.61	9	4	8.9	0.02	9.5e-01	AKTIP BEGAIN GNAI3 HNRNPD HYAL1 MADD PAX5 RPRD2 SEMA3F
Prostate Cancer	1.60	2	0	0.0	0.00	1.0e+00	NMUR2 RP11-6N17.6
Number of treatments/medications taken	1.60	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Smoking status: Previous	1.59	2	0	0.0	0.00	1.0e+00	HECTD4 TMEM161B-AS1
Guilty feelings	1.59	3	0	0.0	0.00	1.0e+00	AP000662.4 MRPS21 TCTA
Arm predicted mass (left)	1.59	16	8	17.8	-0.13	6.3e-01	AKTIP CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 PLCL1 POLR2J3 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA
Qualifications: None of the above	1.58	6	2	4.4	-0.72	1.1e-01	AP000662.4 BSN HYAL1 LIN52 SEMA3F TCTA
Allergy	1.58	6	0	0.0	0.78	3.7e-02	AHSA2 CTD-3074O7.5 CYB561D2 HYAL1 RASSF1 ZNF574
Sensitivity / hurt feelings	1.57	1	0	0.0	0.00	1.0e+00	RMI1
Arm fat-free mass (left)	1.56	13	8	17.8	0.03	9.3e-01	AKTIP FIGNL1 HECTD4 HYAL1 MNAT1 MPPED2 PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Number of operations (self-reported)	1.56	5	0	0.0	-1.00	4.1e-04	BSN HYAL1 PSMB7 SEMA3F TCTA
Pack years adult smoking proportion	1.55	1	0	0.0	0.00	1.0e+00	CYB561
Crohns Disease (2017)	1.54	6	2	4.4	0.98	6.7e-04	AHSA2 GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1
Schizophrenia (2014)	1.54	4	0	0.0	-0.37	6.3e-01	PAX5 RP11-397A16.2 RPRD2 TMEM161B-AS1
Wheeze or whistling in the chest in last year	1.54	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Number of live births	1.53	1	0	0.0	0.00	1.0e+00	PTPN21
Age at First Birth	1.52	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Waist Hip Ratio (WHR)	1.52	13	6	13.3	-0.66	3.9e-03	ALG10 ALG10B ANXA9 CYB561D2 HYAL1 MNAT1 RASSF1 RP11-397A16.2 SEMA3B-AS1 TRIM33 U73166.2 UVSSA YWHAZ
Age at last live birth	1.52	2	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F
Ever had bowel cancer screening	1.52	1	1	2.2	0.00	1.0e+00	PRICKLE4
Basal metabolic rate	1.52	15	8	17.8	-0.10	7.3e-01	AKTIP FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 PAX5 PLCL1 POLR2J3 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Verbal and Numeric Reasoning (VNR)	1.51	6	3	6.7	0.36	4.8e-01	HYAL1 RASSF1 SEMA3F SLC25A5P1 TCTA TRIM37
Qualifications: A levels/AS levels or equivalent	1.51	3	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F TCTA
Mood swings	1.51	3	1	2.2	0.00	1.0e+00	AMIGO1 HYAL1 SEMA3F
Arm predicted mass (right)	1.50	15	8	17.8	-0.05	8.6e-01	AKTIP FIGNL1 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 NAPEPLD PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Qualifications: nursing, teaching	1.50	1	0	0.0	0.00	1.0e+00	RMI1
Schizophrenia (2018)	1.49	6	0	0.0	0.08	8.8e-01	C10orf26 CTD-3074O7.5 FIGNL1 RP11-397A16.2 TMEM161B-AS1 TNFRSF9
Leg predicted mass (left)	1.49	17	5	11.1	0.17	5.2e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 HYAL1 MADD MNAT1 MPPED2 MRPS21 PAX5 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Commuting to job workplace: Car/motor vehicle	1.49	1	1	2.2	0.00	1.0e+00	TOR1AIP2
Leg fat-free mass (right)	1.49	15	6	13.3	0.26	3.5e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 MADD MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Leg predicted mass (right)	1.49	14	6	13.3	0.31	2.9e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 MADD MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 UVSSA YWHAZ
Leg fat-free mass (left)	1.48	16	6	13.3	0.21	4.4e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 HYAL1 MADD MNAT1 MPPED2 MRPS21 PAX5 PLCL1 SEMA3F SLC25A5P1 UVSSA YWHAZ
Past tobacco smoking	1.48	1	0	0.0	0.00	1.0e+00	TMEM161B-AS1
Medication: Cholesterol lowering	1.48	1	1	2.2	0.00	1.0e+00	AMIGO1
Exposure to tobacco smoke outside home	1.48	1	0	0.0	0.00	1.0e+00	GNAI3
Bipolar Disorder or Schizophrenia	1.47	4	3	6.7	0.86	1.4e-01	CTD-3074O7.5 PACS1 RPRD2 TMEM108
Fluid intelligence score	1.47	4	2	4.4	0.59	4.1e-01	AHSA2 HYAL1 SEMA3F TRIM37
Headache pain in last month	1.47	3	1	2.2	0.00	1.0e+00	HECTD4 MRPS21 TARS2
Arm fat-free mass (right)	1.47	15	6	13.3	-0.04	9.0e-01	AKTIP FIGNL1 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 NAPEPLD PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Whole body fat-free mass	1.47	17	8	17.8	-0.06	8.2e-01	AKTIP C1orf54 FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Medication for cholesterol, blood pressure or diabetes	1.46	2	0	0.0	0.00	1.0e+00	AKTIP PPM1N
Whole body water mass	1.46	15	8	17.8	0.07	8.0e-01	AKTIP C1orf54 FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Medication: Metformin	1.45	1	1	2.2	0.00	1.0e+00	PPM1N
Hayfever, allergic rhinitis or eczema	1.45	4	0	0.0	-0.61	3.9e-01	AHSA2 CYB561D2 PLCL1 RASSF1
Allergy or Eczema	1.44	6	1	2.2	0.10	8.5e-01	AHSA2 CTD-3074O7.5 NMUR2 PLCL1 TNFRSF9 ZNF574
Respiratory disease	1.44	3	0	0.0	0.00	1.0e+00	HYAL1 SEMA3F TARS2
Hand grip strength (left)	1.44	5	0	0.0	-0.43	4.7e-01	ANXA9 PPP2R4 RP11-6N17.6 SETDB1 UVSSA
Relative age voice broke	1.44	1	0	0.0	0.00	1.0e+00	ZNF584
Peak expiratory flow (PEF)	1.44	3	0	0.0	0.00	1.0e+00	C1orf54 MRPS21 TARS2
Pulse wave reflection index	1.44	1	0	0.0	0.00	1.0e+00	RMI1
Blood White Count	1.42	15	8	17.8	-0.01	9.7e-01	AHSA2 FAM69A HECTD4 HNRNPDL HTR6 HYAL1 MRPS21 RMI1 RP1-101K10.6 RP11-6N17.6 SDCCAG3 SEMA3F TARS2 ZNF574 ZNF584
Other serious medical condition/disability diagnosed by doctor	1.42	1	0	0.0	0.00	1.0e+00	PRICKLE4
Fed-up feelings	1.42	4	1	2.2	-1.00	4.0e-03	HECTD4 HYAL1 SEMA3F TCTA
Medication: Simvastatin	1.42	1	1	2.2	0.00	1.0e+00	AMIGO1
Trunk fat-free mass	1.42	19	7	15.6	0.03	8.9e-01	AKTIP C1orf54 CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SDCCAG3 SEMA3F SLC25A5P1 TMEM107 UVSSA
Trunk predicted mass	1.42	19	8	17.8	0.04	8.8e-01	AKTIP C1orf54 CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SDCCAG3 SEMA3F SLC25A5P1 TMEM107 UVSSA
Depressed Affect (Nagel 2018)	1.40	4	1	2.2	-1.00	1.9e-03	AMIGO1 HYAL1 SEMA3F TCTA
Alcohol usually taken with meals	1.39	3	0	0.0	0.00	1.0e+00	AP000662.4 PRICKLE4 RMI1
Falls in the last year	1.39	1	0	0.0	0.00	1.0e+00	MPPED2
Asthma	1.39	1	0	0.0	0.00	1.0e+00	SEMA3F
Birth weight of first child	1.38	3	0	0.0	0.00	1.0e+00	C10orf26 C1orf54 HECTD4
Number of full brothers	1.38	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Alzheimer’s Disease (in mother)	1.36	1	0	0.0	0.00	1.0e+00	PAX5
Crohns Disease (2012)	1.36	1	0	0.0	0.00	1.0e+00	SEMA3F
Forced expiratory volume in 1-second (FEV1), predicted	1.36	2	0	0.0	0.00	1.0e+00	CYB561D2 RASSF1
Hand grip strength (right)	1.35	2	0	0.0	0.00	1.0e+00	ANXA9 UVSSA
Forced vital capacity (FVC)	1.35	8	5	11.1	-0.42	2.6e-01	ANXA9 CRY1 CTSS GOLPH3L RP11-397A16.2 SETDB1 TXNL4B ZNF574
Asthma (self-reported)	1.34	2	0	0.0	0.00	1.0e+00	CYB561D2 SEMA3F
Blood Platelet Count	1.33	26	18	40.0	0.34	6.2e-02	AP000662.4 AP2B1 C1orf54 CTSS CYB561D2 GOLPH3L HYAL1 MRPS21 PPM1N PTPN21 RASSF1 RMI1 RP11-397A16.2 RP11-6N17.6 RPRD2 SEMA3B-AS1 SETDB1 SLC25A5P1 TARS2 TMEM161B-AS1 TNFRSF9 TRIM33 U73166.2 VAMP3 YWHAZ ZNF584
Pain type(s) experienced in last month: Hip pain	1.32	2	0	0.0	0.00	1.0e+00	MRPS21 TARS2
Medication for pain relief, constipation, heartburn	1.31	1	0	0.0	0.00	1.0e+00	TARS2
Mouth/teeth dental problems: Mouth ulcers	1.31	2	0	0.0	0.00	1.0e+00	CTSS GOLPH3L
Medication: Paracetamol	1.31	2	1	2.2	0.00	1.0e+00	BSN TCTA
Risk taking	1.31	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Current tobacco smoking	1.30	1	0	0.0	0.00	1.0e+00	SGSM3
Pain experienced in last month	1.29	2	0	0.0	0.00	1.0e+00	HECTD4 TCTA
Breast Cancer	1.27	2	1	2.2	0.00	1.0e+00	AKTIP RASA4
Forced vital capacity (FVC), Best measure	1.26	6	4	8.9	-0.76	4.9e-02	ANXA9 CRY1 CTSS GOLPH3L SETDB1 ZNF574
Medication: Levothyroxine sodium	1.25	1	1	2.2	0.00	1.0e+00	HECTD4
Ever smoked	1.25	2	0	0.0	0.00	1.0e+00	TCTA TMEM161B-AS1
Supplements: Glucosamine	1.24	1	0	0.0	0.00	1.0e+00	TARS2
Medication: Paracetamol	1.23	2	0	0.0	0.00	1.0e+00	BSN TCTA
Cholesterol lowering medication	1.23	1	0	0.0	0.00	1.0e+00	GNAI3
Lung FEV1/FVC ratio	1.21	17	4	8.9	-0.09	7.3e-01	AHSA2 AP000662.4 C1orf54 FAM69A GOLPH3L HNRNPD LIN52 MRPS21 PLCL1 PNMAL2 PPM1N PPP2R4 SETDB1 SLC26A5 TARS2 TRAF3IP1 TRIM33
Medication: Ibuprofen (e.g. Nurofen)	1.21	2	0	0.0	0.00	1.0e+00	HECTD4 TARS2
Age at first live birth	1.21	2	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F
Heel bone mineral density (BMD) T-score, automated (right)	1.20	4	1	2.2	-0.69	2.0e-01	ALG10 BSN RP11-500G22.2 UVSSA
Leg pain on walking	1.20	2	0	0.0	0.00	1.0e+00	PLCL1 SEMA3F
Suffer from 'nerves'	1.19	1	1	2.2	0.00	1.0e+00	MADD
Supplements: Vitamin C	1.19	1	0	0.0	0.00	1.0e+00	PRICKLE4
Mineral and other dietary supplements	1.19	1	0	0.0	0.00	1.0e+00	PRICKLE4
Hypothyroidism (self reported)	1.17	2	1	2.2	0.00	1.0e+00	HECTD4 PSMB7
Forced expiratory volume in 1-second (FEV1)	1.16	6	2	4.4	-0.49	2.7e-01	ANXA9 CTSS GOLPH3L SETDB1 TCTA ZNF574
Standing height	1.16	22	13	28.9	-0.15	4.7e-01	ANXA9 C1orf54 CRY1 CTD-3074O7.5 CYB561D2 FAM69A HECTD4 HNRNPD HP1BP3 HYAL1 MNAT1 MPPED2 MRPS21 PRKRIP1 RASSF1 RMI1 RP11-397A16.2 RP11-6N17.6 SDCCAG3 TMEM107 UVSSA ZNF574
Back pain experienced in last month	1.16	1	0	0.0	0.00	1.0e+00	HECTD4
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.16	1	0	0.0	0.00	1.0e+00	TCTA
Height	1.15	37	23	51.1	-0.09	5.7e-01	ANXA9 C1orf54 CRY1 CTD-3074O7.5 CTSS CYB561D2 FAM69A GOLPH3L HECTD4 HNRNPD HP1BP3 HSDL2 HYAL1 LIN52 MNAT1 MPPED2 MRPS21 PLCL1 PREPL PRICKLE4 PRKRIP1 PTPN21 RASSF1 RMI1 RP11-397A16.2 RP11-500G22.2 RP11-6N17.6 SDCCAG3 SETDB1 TMEM107 TRAF3IP1 TRIM33 TXNL4B U73166.2 UBE2E2 UVSSA ZNF574
Qualifications: O levels/GCSEs or equivalent	1.14	1	0	0.0	0.00	1.0e+00	PRICKLE4
Illnesses of father: Heart disease	1.14	1	0	0.0	0.00	1.0e+00	GNAI3
Alcohol intake frequency.	1.13	4	1	2.2	-0.55	4.5e-01	AP000662.4 HYAL1 SEMA3F TXNL4B
Tinnitus: Yes, now most or all of the time	1.13	1	0	0.0	0.00	1.0e+00	RP11-6N17.6
Coronary Artery Disease (CAD)	1.12	1	0	0.0	0.00	1.0e+00	HECTD4
Mouth/teeth dental problems: Dentures	1.12	1	0	0.0	0.00	1.0e+00	SEMA3F
Hypothyroidism/myxoedema (self-reported)	1.12	1	1	2.2	0.00	1.0e+00	HECTD4
Medication: Amlodipine	1.10	2	0	0.0	0.00	1.0e+00	AHSA2 TRIM37
Osteoporosis (self-reported)	1.10	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Knee pain experienced in last month	1.06	1	0	0.0	0.00	1.0e+00	SEMA3F
Primary Biliary Cirrhosis	1.05	1	0	0.0	0.00	1.0e+00	HECTD4
Diastolic blood pressure, automated reading	1.02	3	1	2.2	0.00	1.0e+00	HECTD4 PAX5 SEMA3F
Systolic Blood Pressure	1.01	8	4	8.9	-0.11	7.9e-01	AP000662.4 C10orf26 CASP9 HECTD4 MADD PSMB7 RP11-6N17.6 SGSM3
Ever used hormone-replacement therapy (HRT)	1.01	1	0	0.0	0.00	1.0e+00	PSMB7
Hair/balding pattern: Pattern 3	1.00	1	0	0.0	0.00	1.0e+00	ALG10
Forced expiratory volume in 1-second (FEV1), Best measure	1.00	4	1	2.2	-0.99	5.4e-03	ANXA9 CTSS GOLPH3L SETDB1
Alzheimer’s Disease (including proxy)	0.99	1	0	0.0	0.00	1.0e+00	PAX5
Cardiovascular Disease	0.99	5	2	4.4	0.56	3.2e-01	AHSA2 HECTD4 MADD PLCL1 TMEM161B-AS1
Heel bone mineral density (BMD) T-score, automated (left)	0.99	3	1	2.2	0.00	1.0e+00	BSN RP11-500G22.2 UVSSA
Mouth/teeth dental problems	0.99	1	0	0.0	0.00	1.0e+00	NMUR2
Vascular/heart problems diagnosed by doctor	0.99	4	0	0.0	0.25	7.5e-01	AHSA2 GNAI3 HECTD4 MADD
HDL Cholesterol	0.98	1	1	2.2	0.00	1.0e+00	MADD
Heel T-Score	0.97	14	9	20.0	-0.26	3.7e-01	ANXA9 AP000662.4 BSN CTSS FOXP4 GOLPH3L GPC6 PSMB7 RMI1 RP11-500G22.2 SEMA3F TCTA TNFRSF9 UVSSA
Medication: Allopurinol	0.96	1	0	0.0	0.00	1.0e+00	VAMP3
Comparative height size at age 10	0.94	11	5	11.1	0.40	2.2e-01	CTD-3074O7.5 HECTD4 HNRNPD HP1BP3 MNAT1 MPPED2 RMI1 SDCCAG3 TMEM107 UVSSA ZNF574
Irritability	0.94	1	0	0.0	0.00	1.0e+00	PAX5
High blood pressure	0.93	4	1	2.2	-0.25	7.5e-01	AHSA2 GNAI3 HECTD4 MADD
Medication: Atenolol	0.93	1	0	0.0	0.00	1.0e+00	HECTD4
Sitting height	0.93	14	6	13.3	-0.13	6.5e-01	ARMC10 C1orf54 CRY1 FAM69A MNAT1 MPPED2 MRPS21 NAPEPLD POLR2J3 RP11-514P8.8 SDCCAG3 TMEM107 UBE2E2 ZNF574
Systolic blood pressure, automated reading	0.92	2	1	2.2	0.00	1.0e+00	C10orf26 HECTD4
Ovarian Cancer	0.90	1	0	0.0	0.00	1.0e+00	RP11-6N17.6
Hypertension (Self-reported)	0.87	4	0	0.0	-0.23	7.7e-01	AHSA2 GNAI3 HECTD4 MADD
Heart disease (mother)	0.86	1	0	0.0	0.00	1.0e+00	HECTD4
Medication: Blood pressure	0.79	2	0	0.0	0.00	1.0e+00	GNAI3 HECTD4
Tanning	0.29	5	3	6.7	-0.74	1.6e-01	CTSS GOLPH3L SETDB1 TMEM161B-AS1 ZNF574
Hair Pigment	0.16	9	3	6.7	-0.35	3.6e-01	HECTD4 MADD MNAT1 MRPS21 RP11-6N17.6 RPRD2 SDCCAG3 SGSM3 TRIM37

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
The Cancer Genome Atlas	Esophageal Carcinoma	3	0.437	2.6
GTEx	Adrenal Gland	3	0.206	2.5
GTEx	Artery Coronary	6	0.507	2.5
GTEx	Cells EBV-transformed lymphocytes	0	0.000	2.5
GTEx	Colon Transverse	11	0.533	2.5
GTEx	Lung	12	0.418	2.5
GTEx	Pituitary	5	0.448	2.5
GTEx	Small Intestine Terminal Ileum	2	0.433	2.5
GTEx	Uterus	3	0.529	2.5
GTEx	Adipose Subcutaneous	12	0.344	2.4
GTEx	Artery Aorta	9	0.302	2.4
GTEx	Brain Cerebellum	8	0.403	2.4
GTEx	Brain Cortex	4	0.387	2.4
GTEx	Brain Frontal Cortex BA9	1	0.108	2.4
GTEx	Brain Hypothalamus	0	0.000	2.4
GTEx	Brain Putamen basal ganglia	6	0.962	2.4
GTEx	Breast Mammary Tissue	11	0.557	2.4
GTEx	Breast Mammary Tissue (Female)	7	0.426	2.4
GTEx	Cells Transformed fibroblasts	13	0.310	2.4
GTEx	Esophagus Gastroesophageal Junction	4	0.277	2.4
GTEx	Esophagus Mucosa	11	0.331	2.4
GTEx	Esophagus Muscularis	15	0.464	2.4
GTEx	Heart Atrial Appendage	6	0.380	2.4
GTEx	Heart Left Ventricle	9	0.588	2.4
GTEx	Liver	2	0.279	2.4
GTEx	Muscle Skeletal	9	0.311	2.4
GTEx	Nerve Tibial	15	0.347	2.4
GTEx	Pancreas	7	0.429	2.4
GTEx	Prostate	4	0.480	2.4
GTEx	Skin Not Sun Exposed Suprapubic	8	0.325	2.4
GTEx	Skin Sun Exposed Lower leg	11	0.302	2.4
GTEx	Spleen	6	0.425	2.4
GTEx	Stomach	3	0.206	2.4
GTEx	Testis	12	0.380	2.4
GTEx	Thyroid	14	0.350	2.4
ROSMAP	Brain Pre-frontal Cortex	16	0.364	2.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.271	2.4
The Cancer Genome Atlas	Soft Tissue Sarcoma	2	0.187	2.4
GTEx	Adipose Visceral Omentum	5	0.245	2.3
GTEx	Artery Tibial	11	0.293	2.3
GTEx	Brain Caudate basal ganglia	3	0.326	2.3
GTEx	Brain Cerebellar Hemisphere	5	0.336	2.3
GTEx	Brain Hippocampus	0	0.000	2.3
GTEx	Brain Nucleus accumbens basal ganglia	2	0.231	2.3
GTEx	Colon Sigmoid	1	0.068	2.3
GTEx	Whole Blood	8	0.402	2.3
NTR	Blood	6	0.250	2.3
CommonMind	Brain Pre-frontal Cortex	13	0.242	2.3
The Cancer Genome Atlas	Breast Invasive Carcinoma	17	0.385	2.3
The Cancer Genome Atlas	Colon Adenocarcinoma	5	0.242	2.3
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	10	0.366	2.3
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.243	2.3
The Cancer Genome Atlas	Brain Lower Grade Glioma	13	0.302	2.3
The Cancer Genome Atlas	Prostate Adenocarcinoma	17	0.367	2.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	2.3
The Cancer Genome Atlas	Stomach Adenocarcinoma	6	0.356	2.3
The Cancer Genome Atlas	Testicular Germ Cell Tumors	6	0.469	2.3
The Cancer Genome Atlas	Thyroid Carcinoma	20	0.387	2.3
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.391	2.3
GTEx	Ovary	0	0.000	2.2
YFS	Blood	7	0.152	2.2
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	7	0.422	2.2
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	2.2
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	14	0.341	2.2
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	6	0.239	2.2
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	3	0.188	2.2
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	2	0.120	2.2
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	2.2
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.144	2.2
GTEx	Breast Mammary Tissue (Male)	1	0.084	2.1
GTEx	Vagina	0	0.000	2.1
METSIM	Adipose	6	0.130	2.1
The Cancer Genome Atlas	Lung Adenocarcinoma	7	0.238	2.1
The Cancer Genome Atlas	Glioblastoma Multiforme	2	0.195	2.0